JENNIFER CYPHER: Open Payments
NPI 1003829706 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 17 payments from 9 companies in 2025. Trend: 2023 $1,130 · 2024 $587 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $158 |
| Lilly USA, LLC | 5 | $83 |
| Inspire Medical Systems, Inc. | 1 | $45 |
| Abbott Laboratories | 2 | $45 |
| Axsome Therapeutics, Inc. | 2 | $31 |
| ABIOMED | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| PFIZER INC. | 1 | $16 |
| Exact Sciences Corporation | 1 | $16 |
Products named: Ozempic, MOUNJARO, INSPIRE, FREESTYLE LIBRE 3, JARDIANCE, Auvelity, AIRSUPRA, Wegovy.
Industry payments across LA — which companies pay providers there.
